About this trial
This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard CT scan for pulmonary embolism, can effectively detect blood clots in the left atrial appendage (LAA) in patients with atrial fibrillation. Detecting these clots is crucial before certain heart procedures to prevent stroke. Currently, a different, more involved procedure (Transesophageal Echocardiography - TEE) is often used. This study will assess if this additional CT scan is feasible, meaning if it can provide clear enough images to identify LAA clots without needing more contrast dye. The study will involve 60 patients, half receiving an "ungated" CT scan and the other half a "gated" CT scan (timed with their heart rhythm). The results of these scans will not be used for immediate patient care during the study, but rather to evaluate the CT scan technique itself. There is no direct benefit to participants, but the information gained could lead to faster diagnosis and reduced unnecessary testing for future patients.
Eligibility criteria
Qualifiers
Patients above 18 years of age years deemed candidates for CT angiography for pulmonary embolism by the primary team on clinical grounds and noted to be in atrial fibrillation at the time.
Room air oxygen saturation above 92%
Systolic blood pressure above 100 mm Hg
Respiratory rate less than 24 breaths/min
Disqualifiers
Inability to personally give informed consent
Pregnant or breastfeeding individuals
Stroke like symptoms
ECG criteria for ischemia or infarction
Trial design
Treatments tested in this trial
- Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus
- Delayed Gated CT Scan for Left Atrial Appendage Thrombus
Treatment groups
Sponsors and collaborators
Northwell Health
Lead sponsor
Canon Medical Systems, USA
Collaborator